Literature DB >> 21901875

In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida.

Aurean D'Eça Júnior1, Anderson França Silva, Fernanda Costa Rosa, Sílvio Gomes Monteiro, Patrícia de Maria Silva Figueiredo, Cristina de Andrade Monteiro.   

Abstract

INTRODUCTION: Candida yeasts are commensals; however, if the balance of normal flora is disrupted or the immune defenses are compromised, Candida species can cause disease manifestations. Several attributes contribute to the virulence and pathogenicity of Candida, including the production of extracellular hydrolytic enzymes, particularly phospholipase and proteinase. This study aimed to investigate the in vitro activity of phospholipases and acid proteinases in clinical isolates of Candida spp.
METHODS: Eighty-two isolates from hospitalized patients collected from various sites of origin were analyzed. Phospholipase production was performed in egg yolk medium and the production of proteinase was verified in a medium containing bovine serum albumin. The study was performed in triplicate.
RESULTS: Fifty-six (68.3%) of isolates tested were phospholipase positive and 16 (44.4%) were positive for proteinase activity. C. tropicalis was the species with the highest number of positive isolates for phospholipase (91.7%). Statistically significant differences were observed in relation to production of phospholipases among species(p<0,0001) and among the strains from different sites of origin (p=0.014). Regarding the production of acid protease, the isolates of C. parapsilosis tested presented a larger number of producers (69.2%). Among the species analyzed, the percentage of protease producing isolates did not differ statistically (χ2=1.9 p=0.5901 (χ2=1.9 p=0.5901).
CONCLUSIONS: The majority of C. non-albicans and all C. albicans isolates were great producers of hydrolytic enzymes and,consequently, might be able to cause infection under favorable conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901875     DOI: 10.1590/s0037-86822011005000036

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  10 in total

1.  Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.

Authors:  Sukumaran Anil; Mohamed Hashem; Sajith Vellappally; Shankargouda Patil; H M H N Bandara; L P Samaranayake
Journal:  Mycopathologia       Date:  2014-08-21       Impact factor: 2.574

2.  Modulation of Candida albicans Biofilm by Different Carbon Sources.

Authors:  Suma C Pemmaraju; Parul A Pruthi; R Prasad; Vikas Pruthi
Journal:  Mycopathologia       Date:  2016-02-22       Impact factor: 2.574

3.  Phenotypic and molecular detection of virulence factor genes SAP4 and PLB in Candida albicans isolates from the Western part of India.

Authors:  Megha Yogesh Pawar; Swarupa Mahesh Hatolkar; Rabindra Nath Misra
Journal:  Med J Armed Forces India       Date:  2020-07-10

Review 4.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

5.  Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates.

Authors:  Carolina do Rosário Esteves Guimarães; Humberto Fonseca de Freitas; Tânia Fraga Barros
Journal:  Mol Biol Rep       Date:  2019-10-10       Impact factor: 2.316

6.  Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA).

Authors:  Chaiene Evelin Zago; Sónia Silva; Paula Volpato Sanitá; Paula Aboud Barbugli; Carla Maria Improta Dias; Virgínia Barreto Lordello; Carlos Eduardo Vergani
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

7.  Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models.

Authors:  Ainara Hernando-Ortiz; Estibaliz Mateo; Aitzol Perez-Rodriguez; Piet W J de Groot; Guillermo Quindós; Elena Eraso
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

8.  Comparison of proteinase activity, hemolysin production, and adherence ability of Candida albicans isolates obtained from gastroesophageal lesions and urinary tract infections.

Authors:  Forough Rezvani; Mehrnoush Maheronnaghsh; Rasoul Mohammadi
Journal:  J Res Med Sci       Date:  2022-07-29       Impact factor: 1.985

9.  Cutaneous candidiasis in Tehran-Iran: from epidemiology to multilocus sequence types, virulence factors and antifungal susceptibility of etiologic Candida species.

Authors:  Golnar Sadeghi; Mina Ebrahimi-Rad; Masoomeh Shams-Ghahfarokhi; Zahra Jahanshiri; Esmat Mirabzadeh Ardakani; Ali Eslamifar; Seyed Fazlollah Mousavi; Mehdi Razzaghi-Abyaneh
Journal:  Iran J Microbiol       Date:  2019-08

10.  Safety Evaluation of Yeasts With Probiotic Potential.

Authors:  Pilar Fernández-Pacheco; Inés María Ramos Monge; Mónica Fernández-González; Justa María Poveda Colado; María Arévalo-Villena
Journal:  Front Nutr       Date:  2021-05-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.